Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "respiratory"

327 News Found

ResMed Q4 revenue up 4%; operating profit up 6%
News | August 16, 2022

ResMed Q4 revenue up 4%; operating profit up 6%

The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.


Sandu Pharmaceuticals launches Sandu Kumarvin
News | August 04, 2022

Sandu Pharmaceuticals launches Sandu Kumarvin

Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.


Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Drug Approval | July 24, 2022

Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market

Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.


U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine
Drug Approval | July 15, 2022

U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine

Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.


Lupin’s Somerset manufacturing plant Receives EIR from US FDA
Drug Approval | July 08, 2022

Lupin’s Somerset manufacturing plant Receives EIR from US FDA

The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated


Eugia Pharma receives USFDA approval for Triamcinolone Acetonide Injectable Suspension
Drug Approval | July 07, 2022

Eugia Pharma receives USFDA approval for Triamcinolone Acetonide Injectable Suspension

This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.


Need for national-level awareness about organ transplant surgeries & organ donation in India
Healthcare | July 05, 2022

Need for national-level awareness about organ transplant surgeries & organ donation in India

People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.


Lupin receives approval from USFDA for Paliperidone extended-release tablets
Drug Approval | July 01, 2022

Lupin receives approval from USFDA for Paliperidone extended-release tablets

Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S


JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories
News | July 01, 2022

JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories

The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores


Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
News | June 16, 2022

Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India

Glenmark is the first company in India to market the innovative FDC of Indacaterol